Hysterectomy Linked to Long-Term Risk for Depression, Anxiety
Hysterectomy, even with ovarian conservation, is associated with an increased long-term risk for de novo depression.
Menopause
Discussing Postmenopausal Vulvovaginal Symptoms at a Well-Woman Visit
Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.
Inclusion of Additional Clinical Factors Does Not Improve FRAX Performance in Postmenopausal Women
Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.
Vasomotor Symptoms at Menopause Linked to Increased Risk for CVD Events
Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.
Higher Estradiol Dose Improves Metabolic Profile in Early But Not Late Postmenopausal Women
Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.
Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause
The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.
Leisure-Time Physical Activity May Attenuate Menopause-Associated Atherogenic Changes
The menopausal transition may be a stronger determinant of serum cardiovascular risk factors than chronologic age.
FSH Levels Prospectively Identify Women at Risk for Perimenopausal Bone Loss
Follicle-stimulating hormone levels may independently predict ongoing or imminent bone loss during the menopausal transition.
Effects of Estrogen-Only Treatment in Women With Prior Hysterectomy
For women aged 50 to 59 years with a history of bilateral oophorectomy, estrogen therapy may have beneficial effects in the long-term.
Effect of Hormone Therapy on Muscle Mass in Postmenopausal Women
Although use of hormone therapy can have some protective effect on muscle mass in postmenopausal women, the benefit is small in the general population.
Next post in General Endocrinology
